- ►prsjournal.com TA Ciulla, PJ Rosenfeld - Current Opinion in Ophthalmology, 2009 - journals.lww.com Recent findings: Two anti-VEGF agents, pegaptanib sodium and ranibizumab, are
currently approved by the United States Food and Drug Administration for the
treatment of neovascular AMD. In addition, off-label use of a third ... Cited by 7 - Related articles - All 5 versions
MIIN ROH, HSUK KIM, JIHUN SONG, JB … - Retina, 2009 - journals.lww.com Skip Navigation Links Home > April 2009 - Volume 29 - Issue 4 > Concentration of
Cytokines in the Aqueous Humor of Patients... ... From the *Department of
Ophthalmology, The Institute of Vision Research; and †Department of ... Cited by 2 - Related articles - All 3 versions
S Sacu, S Michels, F Prager, G Weigert, R … - Eye, 2009 - nature.com In this prospective, randomised, controlled clinical trial, 28 patients were
included. All patients were randomised 1 : 1 to 0.04 ml/1 mg of IVB or PDT plus
same day 0.1 ml/4 mg IVTA (PDT+IVTA). Follow-up examinations were performed ... Cited by 2 - Related articles - All 3 versions
- ►nih.gov PP Yip, CF Woo, HHY Tang, CK Ho - British Journal of Ophthalmology, 2009 - bjo.bmj.com Methods: Consecutive patients with subfoveal choroidal neovascularisation (CNV)
secondary to AMD were treated with PDT using a standard protocol immediately
followed by 1.25 mg of IVB and 4 mg of IVTA. 1.25 mg of IVB was given at 3 ... Cited by 1 - Related articles - All 7 versions
JB Gunther, MM Altaweel - Survey of Ophthalmology, 2009 - Elsevier The use of intravitreal bevacizumab (Avastin) has greatly expanded since its
introduction into ophthalmic care 3 years ago. A PubMed search on 1 August 2008
revealed 51 ocular disease processes that have been treated with ... Cited by 2 - Related articles - All 23 versions
C Leydolt, S Michels, F Prager, G Garhoefer, … - Acta Ophthalmologica, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 1 - Related articles - All 2 versions
- ►prsjournal.com VSE Jeganathan, N Verma - Current Opinion in Ophthalmology, 2009 - journals.lww.com Recent findings: Injecting antivascular endothelial growth factor drugs into the
vitreal cavity brings new hope to many AMD patients. Currently, several
antivascular endothelial growth factor drugs such as pegaptanib, ... Cited by 1 - Related articles - All 3 versions
S Mansoor, BD Kuppermann, MC Kenney - Pharmaceutical research, 2009 - Springer Received August 12, 2008; accepted December 11, 2008; published online January
28, 2009 Abstract. Recently, the use of triamcinolone acetonide (TA) injection
has increased dramatically in treatment for several ocular diseases. Among ... Cited by 1 - Related articles - All 4 versions
